Selected article for: "current study and inflammatory response"

Author: Hasan, Laith K; Deadwiler, Brittney; Haratian, Aryan; Bolia, Ioanna K; Weber, Alexander E; Petrigliano, Frank A
Title: Effects of COVID-19 on the Musculoskeletal System: Clinician’s Guide
  • Cord-id: 7wgd8bq1
  • Document date: 2021_9_21
  • ID: 7wgd8bq1
    Snippet: The global pandemic caused by SARS-CoV-2, or COVID-19, continues to impact all facets of daily life. Clinical manifestations of COVID-19 commonly include musculoskeletal symptoms such as myalgias, arthralgias, and neuropathies/myopathies. The inflammatory response and its impact on the respiratory system have been the focus of most studies. However, the literature is more limited regarding the inflammatory response and its implications for other organ systems, specifically the musculoskeletal sy
    Document: The global pandemic caused by SARS-CoV-2, or COVID-19, continues to impact all facets of daily life. Clinical manifestations of COVID-19 commonly include musculoskeletal symptoms such as myalgias, arthralgias, and neuropathies/myopathies. The inflammatory response and its impact on the respiratory system have been the focus of most studies. However, the literature is more limited regarding the inflammatory response and its implications for other organ systems, specifically the musculoskeletal system. Previous studies have described how systemic inflammation may play a role in bone and joint pathology. Furthermore, it is important to understand the effects current therapeutics used in the treatment of COVID-19 may have on the musculoskeletal system. In this study, we will review the current understanding of the effect COVID-19 has on the musculoskeletal system, provide an overview of musculoskeletal symptoms of patients infected with the virus, and address key issues for clinicians to address during the care of COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • absence presence and local inflammation: 1, 2
    • absence presence and lopinavir ritonavir: 1, 2
    • absence presence and lopinavir ritonavir treatment: 1
    • acute inflammation and local inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute inflammation and lopinavir ritonavir: 1, 2, 3, 4, 5
    • acute inflammation and lopinavir ritonavir treatment: 1
    • acute respiratory distress syndrome and adequately understand: 1, 2
    • acute respiratory distress syndrome and local inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and long term effect: 1
    • acute respiratory distress syndrome and long term impact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lopinavir ritonavir treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • local inflammation and lopinavir ritonavir: 1
    • long term impact and lopinavir ritonavir: 1